4
Changes in Ownership
Alaunos Therapeutics, Inc. Filed Acc 0001140361-18-016245
Options or other derivatives
- Director acquired 1,220 shares (other)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| KIRK RANDAL J Director | 2018-03-29 | Other acquisition · Series 1 Preferred Stock | +1,220 | 123,268 | I | ||
Loading xslF345X03/doc1.xml…